Search tips
Search criteria 


Logo of jcellbiolHomeThe Rockefeller University PressThis articleEditorsContactInstructions for AuthorsThis issue
J Cell Biol. 2016 September 26; 214(7): 793–795.
PMCID: PMC5037414

Blood flow boosts BMP signaling to keep vessels in shape


Bone morphogenic proteins (BMPs) and blood flow regulate vascular remodeling and homeostasis. In this issue, Baeyens et al. (2016. J. Cell Biol. show that blood flow sensitizes endothelial cells to BMP9 signaling by triggering Alk1/ENG complexing to suppress cell proliferation and to recruit mural cells, thereby establishing endothelial quiescence.

How physical forces and signaling events interact in the process of organogenesis and how they integrate to maintain tissue homeostasis is one of the most complex and fascinating questions in biology. The physical influence of blood flow and pressure on the endothelial lining and supporting mural cells of all blood vessels plays a prominent role in forming and maintaining vascular patterning and function. Without blood flow, blood vessels only form a primitive network that does not acquire the hierarchical branching pattern of arteries, capillaries, and veins that ensure efficient tissue supply. Recent studies highlight a multitude of effects of blood flow–mediated shear stress on endothelial cell shape, alignment, gene regulation, and cell–cell signaling events, jointly contributing to proper vascular function. Deregulation of these endothelial adaptations in the adult can cause, or contribute to, severe vascular dysfunction. Although we have learned about many effects, genes, and signaling pathways that are directly or indirectly influenced by flow, and many potential regulators, we still lack fundamental insight into the mechanisms that integrate flow sensing and endothelial responses. To date, we do not know precisely how endothelial cells sense the direction and magnitude of flow or how quantitative flow changes translate into qualitative changes in endothelial cell behavior, such as the inhibition or stimulation of proliferation and recruitment of supporting mural cells. In this issue, Baeyens et al. provide new mechanistic insight into the interaction between blood flow and bone morphogenic protein (BMP) signaling in the vascular disease hereditary hemorrhagic telangiectasia (HHT; Baeyens et al., 2016).

HHT is an inherited genetic disorder that affects blood vessels leading to arteriovenous malformations (AVMs) and bleedings (Peacock et al., 2016). The most common genetic mutations associated with HHT are linked to decreased BMP pathway activity, with heterozygous mutations in the transmembrane proteins endoglin (ENG), activin A receptor–like kinase 1 (ACVRL1/ALK1), and cytosolic sterile α motif domain containing 4A (SMAD4) accounting for almost 85–90% of known familiar cases (Peacock et al., 2016). Acvrl1- or Eng-null mice die at early/mid gestation, with grossly defective vasculature (Arthur et al., 2000; Oh et al., 2000). Inducible homozygous deletion of Alk1 and Eng in adult mice gives rise to AVMs with poor smooth muscle coverage and hemorrhages, with a stronger incidence in Alk1-deficient mice (Park et al., 2008; Mahmoud et al., 2010). Biochemical studies showed that BMP9 and BMP10 activate ALK1, inducing phosphorylation of the intracellular signal-transducing proteins SMAD1, SMAD5, and SMAD8. ENG works as a coreceptor for ALK1, significantly enhancing BMP activity. ALK1/ENG downstream signaling leads to nuclear translocation of activated SMADs that act as transcription factors. ALK1/ENG-dependent gene expression regulates a large range of biological activities, including cell proliferation, migration, and differentiation (Peacock et al., 2016).

Baeyens et al. (2016) observe that AVM formation in retinas of newborn Alk1-deficient mice occurs primarily in areas of higher blood flow, similar to previous observations in the adult mouse (Park et al., 2009). Interestingly, other recent publications have also linked blood flow, ALK1, and AVMs. Beth Roman’s group demonstrated that increases in endothelial cell number in AVMs in ALK1 mutant zebrafish are dependent on flow (Corti et al., 2011). Furthermore, the Roman group proposed that Alk1 expression is regulated by blood flow and that flow activates Alk1-dependent phosphorylation of SMADs downstream of heart-derived BMP10, which is carried by the blood stream (Laux et al., 2013). Likewise, Zhou et al. (2012) also demonstrated that blood oscillatory shear stress in the context of disturbed flow induces phosphorylation of SMAD1 and SMAD5 in endothelial cells in vitro and in vivo. However, this SMAD activation was pro-proliferative and BMP independent (Zhou et al., 2012).

In contrast, Baeyens et al. (2016) demonstrate that blood flow sensitizes endothelial cells toward BMP9, changing its EC50 from 60 pg/ml in no-flow conditions to 3.5 pg/ml when exposed to 1.2 Pa of shear stress. Interestingly, ALK1 and ENG appear to have different roles during BMP9 flow signaling. Whereas ALK1 is required for any BMP9 signaling, ENG seems to be particularly critical for flow-dependent sensitization to low BMP9 concentrations. This finding fits well with the inducible mouse models of HHT and may explain why Alk1 deletion has a stronger impact in AVM formation than deletion of Eng. Mechanistically, Baeyens et al. (2016) propose that blood flow enables a physical interaction between ALK1 and ENG, which is responsible for the increased sensitivity to BMP9. Indeed, the authors were able to coimmunoprecipitate ALK1 and ENG when endothelial cells are exposed to flow but not in the presence of BMP9 alone. Collectively, the results by Baeyens et al. (2016) argue that enhanced BMP signaling is the key mediator for endothelial quiescence in response to flow (Fig. 1). Knockdown of either ALK1 or ENG reversed two known but critical effects of shear stress on endothelial cells: suppression of proliferation and mural cell recruitment (Baeyens et al., 2016). Intriguingly, in mice where ALK1 was randomly deleted in a subpopulation of labeled endothelial cells, only the ALK1-deficient cells proliferated more and showed decreased mural cell coverage. Given that endothelial cell proliferation and reduced recruitment of mural cells have previously been suggested to drive AVM formation, the newly identified convergence of blood flow and BMP signaling on these processes provides a molecular mechanism for the development of HHT lesions when ALK1 or ENG are defective.

Figure 1.
Blood flow promotes ALK1/ENG association to increase BMP9 sensitivity. In the absence of blood flow and at low concentrations of BMP9, ALK1 is not able to phosphorylate its downstream effectors SMAD1/5/8. However, in the presence of blood flow, shear ...

Like any good research, the current work by Baeyens et al. (2016) not only provides new insight but also raises further questions. How shear stress triggers the formation of a complex between Alk1 and ENG, and whether this interaction itself functions as a real rheostat for SMAD phosphorylation, remains unclear. Moreover, it is not clear why this interaction activates mostly SMAD1, and SMAD5 to a lesser extent, but not SMAD8. Whether SMAD1 is functionally involved also remains untested, although the genetic contribution to HHT by SMAD4 mutations clearly suggests that a SMAD complex should be part of the mechanism. Given the multiple levels of cell-intrinsic dynamic regulation of SMAD shuttling and transcriptional activity, future work is needed to unravel whether flow and BMP signaling provide a system of reinforcement of a tonic (continuous and sustained) stimulus or whether, like in other signaling circuits, oscillatory patterns and temporal effects become important. Is there an upstream flow sensor such as Piezo1 and are the calcium signals known to be activated by flow required for Alk1/ENG complexing? It would be interesting to test the potential contribution of the transmembrane protein 100 as it has been shown to be involved in BMP9-ALK1 signaling and AVM formation (Somekawa et al., 2012) and to regulate calcium influx (Weng et al., 2015), a known mediator of flow signaling, in cells. Another open question is the link between BMP and Notch signaling in AVM formation. Both pathways have now been demonstrated to regulate AVM onset and both regulate common endothelial behaviors, such as cell migration and proliferation (Murphy et al., 2008). Notch and BMP signaling cross talk at different levels and can be synergistic or antagonistic depending on the cellular context. SMADs and Notch intracellular domain can physically interact to promote expression of the Notch-dependent target genes HES1 and HEY1/2, which can modulate endothelial fate (Itoh et al., 2004).

In addition to these open questions directly related to the biochemical pathway involved, the cell biological and morphogenic mechanism of AVM or other vascular malformations also requires further elucidation. Whereas the work by Baeyens et al. (2016) highlights clonal endothelial proliferation as a major effect of deficient BMP signaling, a recent study linked ALK1 activity to endothelial cell migratory behavior in response to flow. Rochon et al. (2016) showed that in zebrafish development, Alk1-positive endothelial cells generally migrate against the direction of blood flow, but Alk1-deficient cells showed an impaired capacity to migrate against the flow direction. Altered endothelial cell migration results in an imbalanced distribution of cells within the network, thereby contributing to formation and enlargement of AVMs. Although the relevant ligand in the zebrafish system appears to be BMP10 and, unlike the mouse work, the AVMs in the study by Rochon et al. (2016) form during vascular development, it is possible that AVMs in general are a result of several altered endothelial behaviors, in addition to proliferation. Recent papers from different groups have demonstrated that endothelial cells exhibit a surprising degree of motility during the process of vessel remodeling. For instance, vessel regression, an essential step in vascular remodeling, is driven by migration of endothelial cells from the regressing vessel segments into neighboring segments (Chen et al., 2012; Franco et al., 2015; Lenard et al., 2015), a process dependent on blood flow (Chen et al., 2012; Franco et al., 2016). Endothelial cells polarize against the flow direction and this provides a directional cue to coordinate endothelial cell movements within the vascular network (Udan et al., 2013; Franco et al., 2016). If and how the mechanisms governing developmental remodeling are different, or similar, to those that control the maintenance of vascular patterning in the adult remains to be seen. It will therefore be critical to investigate the contribution of proliferation and migration in the development of AVMs and HHT, and how those two cellular behaviors are under the molecular control of ALK1/ENG and flow signaling. It must be anticipated that the identified Alk1/ENG complex will not remain the only signaling hub in the regulation of vascular homeostasis.

From a clinical perspective, understanding the mechanism of HHT is important but remains unsatisfactory as long as we cannot develop effective disease prevention, cure, or at least symptomatic treatment. Changing flow conditions in blood vessels are part of everyday life and HHT patients carry heterozygosity for one of the key BMP signaling components in all cells. Can we learn how to maintain the sensitivity of or resensitize endothelial cells to BMP from this study by Baeyens et al. (2016) of the integration of flow and BMP signaling? Would triggering complex formation between Alk1 and ENG in all vessels be safe? Predicting where the fundamental breakthrough for therapeutic developments will come from is notoriously difficult, but new mechanistic insight, such as the one provided here, represents a promising starting point.


The references in this Spotlight are not exhaustive and we apologize to those authors whose work on this topic could not be cited because of space limitations.

C.A. Franco was supported by a Fundação para a Ciência e a Tecnologia investigator (IF/00412/2012), a Fundação para a Ciência e a Tecnologia grant (EXPL/BEX-BCM/2258/2013), the Portugal2020 program (LISBOA-01-0145-FEDER-00739), and a European Research Council starting grant (AXIAL.EC; 679368). H. Gerhardt is supported by European Research Council consolidator grant (REshape; 311719).

The authors declare no competing financial interests.


  • Arthur H.M., Ure J., Smith A.J., Renforth G., Wilson D.I., Torsney E., Charlton R., Parums D.V., Jowett T., Marchuk D.A., et al. 2000. Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev. Biol. 217:42–53. 10.1006/dbio.1999.9534 [PubMed] [Cross Ref]
  • Baeyens N., Larrivée B., Ola R., Hayward-Piatkowskyi B., Dubrac A., Huang B., Ross T.D., Coon B.G., Min E., Tsarfati M., et al. 2016. Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia. J. Cell Biol. 10.1083/jcb.201603106 [PMC free article] [PubMed] [Cross Ref]
  • Chen Q., Jiang L., Li C., Hu D., Bu J.W., Cai D., and Du J.L. 2012. Haemodynamics-driven developmental pruning of brain vasculature in zebrafish. PLoS Biol. 10:e1001374 10.1371/journal.pbio.1001374 [PMC free article] [PubMed] [Cross Ref]
  • Corti P., Young S., Chen C.Y., Patrick M.J., Rochon E.R., Pekkan K., and Roman B.L. 2011. Interaction between alk1 and blood flow in the development of arteriovenous malformations. Development. 138:1573–1582. 10.1242/dev.060467 [PubMed] [Cross Ref]
  • Franco C.A., Jones M.L., Bernabeu M.O., Geudens I., Mathivet T., Rosa A., Lopes F.M., Lima A.P., Ragab A., Collins R.T., et al. 2015. Dynamic endothelial cell rearrangements drive developmental vessel regression. PLoS Biol. 13:e1002125 10.1371/journal.pbio.1002125 [PMC free article] [PubMed] [Cross Ref]
  • Franco C.A., Jones M.L., Bernabeu M.O., Vion A.C., Barbacena P., Fan J., Mathivet T., Fonseca C.G., Ragab A., Yamaguchi T.P., et al. 2016. Non-canonical Wnt signalling modulates the endothelial shear stress flow sensor in vascular remodelling. eLife. 5:e07727 10.7554/eLife.07727 [PMC free article] [PubMed] [Cross Ref]
  • Itoh F., Itoh S., Goumans M.J., Valdimarsdottir G., Iso T., Dotto G.P., Hamamori Y., Kedes L., Kato M., and ten Dijke Pt P. 2004. Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J. 23:541–551. 10.1038/sj.emboj.7600065 [PubMed] [Cross Ref]
  • Laux D.W., Young S., Donovan J.P., Mansfield C.J., Upton P.D., and Roman B.L. 2013. Circulating Bmp10 acts through endothelial Alk1 to mediate flow-dependent arterial quiescence. Development. 140:3403–3412. 10.1242/dev.095307 [PubMed] [Cross Ref]
  • Lenard A., Daetwyler S., Betz C., Ellertsdottir E., Belting H.G., Huisken J., and Affolter M. 2015. Endothelial cell self-fusion during vascular pruning. PLoS Biol. 13:e1002126 10.1371/journal.pbio.1002126 [PMC free article] [PubMed] [Cross Ref]
  • Mahmoud M., Allinson K.R., Zhai Z., Oakenfull R., Ghandi P., Adams R.H., Fruttiger M., and Arthur H.M. 2010. Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ. Res. 106:1425–1433. 10.1161/CIRCRESAHA.109.211037 [PubMed] [Cross Ref]
  • Murphy P.A., Lam M.T., Wu X., Kim T.N., Vartanian S.M., Bollen A.W., Carlson T.R., and Wang R.A. 2008. Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice. Proc. Natl. Acad. Sci. USA. 105:10901–10906. 10.1073/pnas.0802743105 [PubMed] [Cross Ref]
  • Oh S.P., Seki T., Goss K.A., Imamura T., Yi Y., Donahoe P.K., Li L., Miyazono K., ten Dijke P., Kim S., and Li E. 2000. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA. 97:2626–2631. 10.1073/pnas.97.6.2626 [PubMed] [Cross Ref]
  • Park S.O., Lee Y.J., Seki T., Hong K.H., Fliess N., Jiang Z., Park A., Wu X., Kaartinen V., Roman B.L., and Oh S.P. 2008. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood. 111:633–642. 10.1182/blood-2007-08-107359 [PubMed] [Cross Ref]
  • Park S.O., Wankhede M., Lee Y.J., Choi E.J., Fliess N., Choe S.W., Oh S.H., Walter G., Raizada M.K., Sorg B.S., and Oh S.P. 2009. Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J. Clin. Invest. 119:3487–3496. 10.1172/JCI39482 [PMC free article] [PubMed] [Cross Ref]
  • Peacock H.M., Caolo V., and Jones E.A. 2016. Arteriovenous malformations in hereditary haemorrhagic telangiectasia: looking beyond ALK1-NOTCH interactions. Cardiovasc. Res. 109:196–203. 10.1093/cvr/cvv264 [PubMed] [Cross Ref]
  • Rochon E.R., Menon P.G., and Roman B.L. 2016. Alk1 controls arterial endothelial cell migration in lumenized vessels. Development. 143:2593–2602. 10.1242/dev.135392 [PubMed] [Cross Ref]
  • Somekawa S., Imagawa K., Hayashi H., Sakabe M., Ioka T., Sato G.E., Inada K., Iwamoto T., Mori T., Uemura S., et al. 2012. Tmem100, an ALK1 receptor signaling-dependent gene essential for arterial endothelium differentiation and vascular morphogenesis. Proc. Natl. Acad. Sci. USA. 109:12064–12069. 10.1073/pnas.1207210109 [PubMed] [Cross Ref]
  • Udan R.S., Vadakkan T.J., and Dickinson M.E. 2013. Dynamic responses of endothelial cells to changes in blood flow during vascular remodeling of the mouse yolk sac. Development. 140:4041–4050. 10.1242/dev.096255 [PubMed] [Cross Ref]
  • Weng H.J., Patel K.N., Jeske N.A., Bierbower S.M., Zou W., Tiwari V., Zheng Q., Tang Z., Mo G.C., Wang Y., et al. 2015. Tmem100 is a regulator of TRPA1-TRPV1 complex and contributes to persistent pain. Neuron. 85:833–846. 10.1016/j.neuron.2014.12.065 [PMC free article] [PubMed] [Cross Ref]
  • Zhou J., Lee P.L., Tsai C.S., Lee C.I., Yang T.L., Chuang H.S., Lin W.W., Lin T.E., Lim S.H., Wei S.Y., et al. 2012. Force-specific activation of Smad1/5 regulates vascular endothelial cell cycle progression in response to disturbed flow. Proc. Natl. Acad. Sci. USA. 109:7770–7775. 10.1073/pnas.1205476109 [PubMed] [Cross Ref]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press